Novel genetic therapeutic approaches for modulating the severity of β‑ thalassemia (Review)
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? | Haematologica
Safety and efficacy of thalidomide in patients with transfusion-dependent β- thalassemia: a randomized clinical trial | Signal Transduction and Targeted Therapy
Frontiers | New Insights Into Pathophysiology of β-Thalassemia
Current status of beta‐thalassemia and its treatment strategies - Ali - 2021 - Molecular Genetics & Genomic Medicine - Wiley Online Library
An urgent need for improving thalassemia care due to the wide gap in current real-life practice and clinical practice guidelines | Scientific Reports
Current and future alternative therapies for beta-thalassemia major - ScienceDirect
New treatment strategies for β-thalassemia | Encyclopedia MDPI
Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia
A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies? - ScienceDirect
Full article: Revisiting beta thalassemia intermedia: past, present, and future prospects
Beta Thalassemia: Practice Essentials, Etiology, Epidemiology
Antioxidants as Complementary Medication in Thalassemia | IntechOpen
Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
Sirolimus for Treatment of β-Thalassemia: From Pre-Clinical Studies to the Design of Clinical Trials
Diseases | Free Full-Text | Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis
Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β- thalassemia | Haematologica
PDF) Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm
Pathophysiology and treatment of patients with... | F1000Research
